Gene gun-mediated IL-12 gene therapy induces antitumor effects in the absence of toxicity: a direct comparison with systemic IL-12 protein therapy.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Journal of immunotherapy

• Publication date

  1999-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00002371-199903000-00005PMID 10093038
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cytokine Gene Therapy of Cancer Using Gene Gun Technology: Superior Antitumor Activity of Interleukin-12

  1997cited by this paper
• Gene gun-mediated skin transfection with interleukin 12 gene results in regression of established primary and metastatic murine tumors.

  1996cited by this paper
• IL-12: a key cytokine in immune regulation.

  1996cited by this paper
• Injection of complementary DNA encoding interleukin-12 inhibits tumor establishment at a distant site in a murine renal carcinoma model.

  1996cited by this paper
• After initial setback, IL-12 regaining popularity.

  1996cited by this paper
• Amount of interleukin 12 available at the tumor site is critical for tumor regression.

  1996cited by this paper
• IL-12 administered in vivo to young and aged mice. Discrepancy between the effects on tumor growth in vivo and cytotoxic T lymphocyte generation ex vivo: dependence on IFN-gamma.

  1996cited by this paper
• Interleukin-12.

  1995cited by this paper
• B7-1 and interleukin 12 synergistically induce effective antitumor immunity.

  1995cited by this paper
• High cytokine production and effective antitumor activity of a recombinant vaccinia virus encoding murine interleukin 12.

  1995cited by this paper
• Influence of interleukin 12 on p53 peptide vaccination against established Meth A sarcoma.

  1995cited by this paper
• Mechanism of interleukin 12-mediated toxicities during experimental viral infections: role of tumor necrosis factor and glucocorticoids

  1995cited by this paper
• Administration of recombinant interleukin 12 prevents outgrowth of tumor cells metastasizing spontaneously to lung and lymph nodes.

  1995cited by this paper
• Cancer immunotherapy of established tumors with IL-12. Effective delivery by genetically engineered fibroblasts.

  1995cited by this paper
• Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vector.

  1995cited by this paper
• Role of interferon-gamma in mediating the antitumor efficacy of interleukin-12.

  1995cited by this paper
• IL-12 Deaths: Explanation and a Puzzle

  1995cited by this paper
• Systemic administration of rIL-12 induces complete tumor regression and protective immunity: response is correlated with a striking reversal of suppressed IFN-gamma production by anti-tumor T cells.

  1995cited by this paper
• Interleukin‐12 is required for interferon‐γ production and lethality in lipopolysaccharide‐induced shock in mice

  1995cited by this paper
• Interleukin-12 inhibits murine graft-versus-host disease.

  1995cited by this paper
• Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production.

  1994cited by this paper
• Administration of recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFN-gamma in vivo.

  1994cited by this paper
• Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo.

  1994cited by this paper
• Antitumor and antimetastatic activity of interleukin 12 against murine tumors

  1993cited by this paper
• Induction of Ly-6A/E expression by murine lymphocytes after in vivo immunization is strictly dependent upon the action of IFN-alpha/beta and/or IFN-gamma.

  1991cited by this paper
• Ly 1+2- suppressor T cells down-regulate the generation of Ly 1-2+ effector T cells during progressive growth of the P815 mastocytoma.

  1985cited by this paper
• T cell-mediated suppression of the concomitant antitumor immune response as an example of transplantation tolerance.

  1984cited by this paper

• Interleukin-12 in multimodal tumor therapies for induction of anti-tumor immunity

  2024cites this paper
• Interleukin-12 as an in situ cancer vaccine component: a review

  2022cites this paper
• A novel method for the development of plasmid DNA-loaded nanoliposomes for cancer gene therapy

  2021cites this paper
• Systemic sterile induced-co-expression of IL-12 and IL-18 drives IFN-γ-dependent activation of microglia and recruitment of MHC-II-expressing inflammatory monocytes into the brain

  2020cites this paper
• Nanotechnology approaches in the current therapy of skin cancer.

  2020cites this paper
• Lipid gene nanocarriers for the treatment of skin diseases: Current state‐of‐the‐art

  2019cites this paper
• Rapid Induction of IL-10 without Affecting IL-12-Induced Systemic Toxicity through a Coexpression of IL-18 Strongly Attenuates

  2017cites this paper
• Melanoma treatment with intratumoral electroporation of tavokinogene telseplasmid (pIL-12, tavokinogene telseplasmid).

  2017cites this paper
• Abrogation of TNFα Production during Cancer Immunotherapy Is Crucial for Suppressing Side Effects Due to the Systemic Expression of IL-12

  2014cites this paper
• Synergistic antitumoral effect of IL-12 gene cotransfected with antiangiogenic genes for angiostatin, endostatin, and saxatilin.

  2014cites this paper
• Improved Anti-tumor Immunity Using Xenogenic Melanoma DNA Vaccines Combined with IL-12 and Ii-PADRE in Murine Melanoma

  2014cites this paper
• Equine melanocytic tumors.

  2013cites this paper
• Safety and Immunogenicity of an HIV-1 Gag DNA Vaccine with or without IL-12 and/or IL-15 Plasmid Cytokine Adjuvant in Healthy, HIV-1 Uninfected Adults

  2012cites this paper
• Cytokines as anti-angiogenic agents in haematological malignancies.

  2011cites this paper
• Double-blind Placebo-controlled Study With Interleukin-18 and Interleukin-12-encoding Plasmid DNA Shows Antitumor Effect in Metastatic Melanoma in Gray Horses

  2011cites this paper
• IL-12 initiates tumor rejection via LTi cells bearing the natural cytotoxicity receptor NKp46

  2011cites this paper
• Therapeutic potential of human mesenchymal stem cells producing IL-12 in a mouse xenograft model of renal cell carcinoma.

  2010cites this paper
• Cancer electrogene therapy with interleukin-12.

  2010cites this paper
• Electrogene therapy with interleukin-12 in canine mast cell tumors

  2010cites this paper
• Studies of human T cell costimulation: potential for the immunotherapy of cancer

  2010cites this paper
• UČINKI ELEKTRI ČNO POSREDOVANEGA VNOSA PLAZMIDNE DNA, KI NOSI ZAPIS ZA INTERLEVKIN-12, PRI ZDRAVLJENJU INDUCIRANIH TUMORJEV MIäI IN SPONTANIH TUMORJEV PSOV

  2010cites this paper
• Nanoparticle-mediated interleukin-12 cancer gene therapy.

  2010cites this paper
• New perspectives for melanoma immunotherapy: role of IL-12.

  2009cites this paper
• Coexpression of IL-18 Strongly Attenuates IL-12-Induced Systemic Toxicity through a Rapid Induction of IL-10 without Affecting its Antitumor Capacity1

  2009cites this paper
• Inhibition of a vascular ocular tumor growth by IL-12 gene transfer

  2007cites this paper
• A phase I trial of hyperthermia-induced interleukin-12 gene therapy in spontaneously arising feline soft tissue sarcomas

  2007cites this paper
• Immunotherapy of cancer by IL-12-based cytokine combinations

  2007cites this paper
• Electroporation-mediated gene therapy

  2007cites this paper
• Intratumoral injection of IL-12 plasmid DNA – results of a phase I/IB clinical trial

  2007cites this paper
• Intraoperative subcutaneous or intrasplenic vaccination with modified autologous tumor cells leads to enhanced survival in a mouse tumor model

  2006cites this paper
• Anti-angiogenic effects of interleukin-12 delivered by a novel hyperthermia induced gene construct

  2006cites this paper
• Evaluation of Toxicity following Electrically Mediated Interleukin-12 Gene Delivery in a B16 Mouse Melanoma Model

  2006cites this paper
• Immunization with autologous T cells enhances in vivo anti-tumor immune responses accompanied by up-regulation of GADD45β

  2006cites this paper
• Phase I trial of combined treatment with ch14.18 and R24 monoclonal antibodies and interleukin-2 for patients with melanoma or sarcoma

  2006cites this paper
• Particle-Mediated Cytokine Gene Therapy Leads to Antitumor and Antimetastatic Effects in Mouse Carcinoma Models

  2006cites this paper
• Intratumoral Administration of a Recombinant Canarypox Virus Expressing Interleukin 12 in Patients with Metastatic Melanoma

  2005cites this paper
• Nonviral Vector Systems for Cancer Gene Therapy

  2005cites this paper
• Gene Therapy for Patients With Head and Neck Cancer

  2005cites this paper
• Electroporation for targeted gene transfer

  2005cites this paper
• Intestinal Allergic Diarrhea Nasal IL-12p70 DNA Prevents and Treats

  2005cites this paper
• Dendritic cell immunotherapy with poly(d,l‐2,4‐diaminobutyric acid)‐mediated intratumoral delivery of the interleukin‐12 gene suppresses tumor growth significantly

  2005cites this paper
• Einsatz von Interleukin-12 und Interleukin-18 kodierender Plasmid-DNA zur Therapie von Melanomen beim Schimmel

  2005cites this paper
• Nasal IL-12p70 DNA Prevents and Treats Intestinal Allergic Diarrhea1

  2005cites this paper
• Combined therapy with flk1-based DNA vaccine and interleukin-12 results in enhanced antiangiogenic and antitumor effects.

  2005cites this paper
• Gene delivery: intelligent but just at the beginning

  2004cites this paper
• Treatment of experimental breast cancer using interleukin-12 gene therapy combined with anti-vascular endothelial growth factor receptor-2 antibody.

  2004cites this paper
• IL-12 cDNA direct injection: antimetastatic effect from a single injection in a murine hepatic metastases model.

  2004cites this paper
• Natural killer cell depletion confounds the antitumor mechanism of endogenous IL‐12 overexpression

  2004cites this paper
• Formalin-fixed tumor cells effectively induce antitumor immunity both in prophylactic and therapeutic conditions.

  2004cites this paper
• A Combination of flk1-Based DNA Vaccine and an Immunomodulatory Gene (IL-12) in the Treatment of Murine Cancer

  2004cites this paper
• Complete tumour regressions induced by vaccination with IL-12 gene-transduced tumour cells in combination with IL-15 in a melanoma model in mice

  2004cites this paper
• An investigation of in vitro-assembled chromatin as a novel vehicle for gene delivery

  2004cites this paper
• Human cancer gene therapy with cytokine gene-modified cells

  2004cites this paper
• IP‐10‐encoding plasmid DNA therapy exhibits anti‐tumor and anti‐metastatic efficiency

  2004cites this paper
• Cell targeting in anti-cancer gene therapy.

  2004cites this paper
• Gene Therapy of Anaplastic Thyroid Carcinoma with a Single-Chain Interleukin-12 Fusion Protein

  2003cites this paper
• Dendritic cells transfected with interleukin‐12 and pulsed with tumor extract inhibit growth of murine prostatic carcinoma in vivo

  2003cites this paper
• Tumor regression by repeated intratumoral delivery of water soluble lipopolymers/p2CMVmIL-12 complexes.

  2003cites this paper
• IL-12 Gene Therapy Using an Electrically Mediated Nonviral Approach Reduces Metastatic Growth of Melanoma

  2003cites this paper
• Polymeric Gene Delivery Systems

  2003cites this paper
• Delivery of IL-12 intranasally leads to reduced IL-12-mediated toxicity.

  2003cites this paper
• ANTITUMOR IMMUNITY AND VACCINE EFFECT INDUCED BY IL-12 SYNERGIZES B7-1 GENE TRANSFECTED CELLS

  2003cites this paper
• Optimized expression and specific activity of IL-12 by directed molecular evolution

  2003cites this paper
• Safety of Interleukin-12 Gene Therapy Against Cancer: A Murine Biodistribution and Toxicity Study

  2003cites this paper
• Gene gun-based co-immunization of merozoite surface protein-1 cDNA with IL-12 expression plasmid confers protection against lethal Plasmodium yoelii in A/J mice.

  2003cites this paper
• A convenient cancer vaccine therapy with in vivo transfer of interleukin 12 expression plasmid using gene gun technology after priming with irradiated carcinoma cells

  2002influential citation
• IL-12 plasmid delivery by in vivo electroporation for the successful treatment of established subcutaneous B16.F10 melanoma.

  2002cites this paper
• Intratumoral injection of interleukin-12 plasmid DNA, either naked or in complex with cationic lipid, results in similar tumor regression in a murine model.

  2002cites this paper
• Antibody-cytokine fusion proteins: harnessing the combined power of cytokines and antibodies for cancer therapy.

  2002cites this paper
• Complex cancer gene therapy in mice melanoma

  2002cites this paper
• Effective gene therapy for medullary thyroid carcinoma using recombinant adenovirus inducing tumor-specific expression of interleukin-12

  2002cites this paper
• Biodegradable polymer-based interleukin-12 gene delivery: role of induced cytokines, tumor infiltrating cells and nitric oxide in anti-tumor activity

  2002cites this paper
• Needle-free epidermal powder immunization

  2002cites this paper
• SHORT ANALYTICAL REVIEW Antibody-Cytokine Fusion Proteins: Harnessing the Combined Power of Cytokines and Antibodies for Cancer Therapy 1

  2002cites this paper
• Low-Dose Vaccinia Virus-Mediated Cytokine Gene Therapy of Glioma

  2001cites this paper
• Transduction of human MCP‐3 by a parvoviral vector induces leukocyte infiltration and reduces growth of human cervical carcinoma cell xenografts

  2001cites this paper
• Gene therapy: optimising DNA delivery to the nucleus.

  2001cites this paper
• IL-12 gene therapy of leukemia with hematopoietic progenitor cells without the toxicity of systemic IL-12 treatment.

  2001cites this paper
• New prospectives of prostate cancer gene therapy: molecular targets and animal models.

  2001cites this paper
• Gene Gun Transfection of Human Glioma and Melanoma Cell Lines with Genes Encoding Human IL-12 and GM-CSF

  2000cites this paper
• Soluble biodegradable polymer-based cytokine gene delivery for cancer treatment.

  2000cites this paper
• Interleukin-12 gene therapy of a weakly immunogenic mouse mammary carcinoma results in reduction of spontaneous lung metastases via a T-cell-independent mechanism

  2000cites this paper
• Direct transfer of IL-12 gene into growing Renca tumors.

  2000cites this paper
• Development of biomaterials for gene therapy.

  2000cites this paper
• Induction of long-lasting cytokine effect by injection of IL-12 encoding plasmid DNA

  2000cites this paper
• The gene gun: current applications in cutaneous gene therapy

  2000cites this paper
• CHAPTER 30 – GENE-BASED THERAPEUTICS

  2000cites this paper
• Interleukin-12. Opportunities for the treatment of bladder cancer.

  2000cites this paper
• Cytokine Gene Therapy for Cancer with Naked DNA

  2000cites this paper
• Efficient transformation of Dictyostelium discoideum with a particle inflow gun.

  2000cites this paper
• Antitumoral effect of interleukin-12-secreting fibroblasts in a mouse model of ovarian cancer: Implications for the use of ovarian cancer biopsy-derived fibroblasts as a vehicle for regional gene therapy

  2000cites this paper
• How realistic is cutaneous gene therapy?

  1999cites this paper